Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro

Biomedicine and Pharmacotherapy

Volumn 63, Issue 7, 2009, Pages 484-491

  Liu, Jinfeng ^a   Wang, Xuan ^a   Wang, Fengshan ^a   Teng, Li ^a   Cao, Jichao ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Bleomycin; Cu,Zn superoxide dismutase; Heparin superoxide dismutase; Hydroxyproline; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; HYDROXYPROLINE; INTERLEUKIN 1BETA; LOW MOLECULAR WEIGHT HEPARIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FIBROBLAST; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ANIMALS; BLEOMYCIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION; HEPARIN; HYDROXYPROLINE; INFLAMMATION; INTERLEUKIN-1BETA; LUNG; MALE; MICE; PULMONARY FIBROSIS; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; X-RAYS;

EID: 68049095043     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.04.009     Document Type: Article

References (56)

1. Noth I., and Martinez F.J. Recent advances in idiopathic pulmonary fibrosis. Chest 132 (2007) 637-650
2. Mason R.J., Schwarz M.I., Hunninghake G.W., and Musson R.A. NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future: Am J Respir Crit Care Med 160 (1999) 1771-1777
3. MacNee W., and Rahman I. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 50 suppl 1 (1995) S53-S58
4. Gauldie J., Jordana M., and Cox G. Cytokines and pulmonary fibrosis. Thorax 48 (1993) 931-935
5. Strausz J., Muller-Quernheim J., Steppling H., and Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 141 (1990) 124-128
6. Crystal R.G., Bitterman P.B., Rennard S.I., Hance A.J., and Keogh B.A. Interstitial lung diseases of unknown cause: disorders characterised by chronic inflammation of the lower respiratory tract. N Engl J Med 310 (1984) 154-166
7. Bellocq A., Azoulay E., Marullo S., Flahault A., Phillipe C., Cadranel J., and Baud L. Reactive oxygen and nitrogen intermediates increase transforming growth factor beta 1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 21 (1999) 128-136
8. Hagimoto N., Kuwano K., Inoshima I., Yoshimi M., Nakamura N., Fujita M., Maeyama T., and Hara N. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 168 (2002) 6470-6478
9. Liu T., Dhanasekaran S.M., Jin H., Hu B., Tomlins S.A., Chinnaiyan A.M., and Phan S.H. FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol 164 (2004) 1315-1326
10. Zuo F., Kaminski N., Eugui E., Allard J., Yakhini Z., Ben-Dor A., Lollini L., Morris D., Kim Y., DeLustro B., Sheppard D., Pardo A., and Selman M. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 99 (2002) 6292-6297
11. Aso Y., Toneda K., and Kikkawa Y. Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest 35 (1976) 558-568
12. Izbicki G., Segel M.J., Christensen T.G., Conner M.W., and Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 83 (2002) 111-119
13. Daba M.H., Abdel-Aziz A.A., Moustafa A.M., Al-Majed A.A., Al- Shabanah O.A., and El-Kashef H.A. Effects of L-carnitine and ginkgo biloba extract (EG b 761) in experimental bleomycin-induced lung fibrosis. Pharmacol Res 45 (2002) 461-467
14. Swaisgood C.M., French E.L., Noga C., Simon R.H., and Ploplis V.A. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157 (2000) 177-187
15. Wells A.U. Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled. Eur Respir J 27 (2006) 664-666
16. Hunninghake G.W. Antioxidant therapy for idiopathic pulmonary fibrosis. N Engl J Med 353 (2005) 2285-2287
17. Epperly M.W., Bray J.A., Krager S., Berry L.M., Gooding W., Engelhardt J.F., Zwacka R., Travis E.L., and Greenberger J.S. Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Radiat Oncol Biol Phys 43 (1999) 169-181
18. Epperly M.W., Epstein C.J., Travis E.L., and Greenberger J.S. Decreased pulmonary radiation resistance of manganese superoxide dismutase (MnSOD)-deficient mice is corrected by human manganese superoxide dismutase-plasmodia/liposome (SOD2-PL) intratracheal gene therapy. Radiat Res 154 (2000) 365-374
19. Epperly M.W., Travis E.L., Whitsett J.A., Raineri I., Epstein C.J., and Greenberger J.S. Overexpression of manganese superoxide dismutase(MnSOD) in whole lung or alveolar type II cells of MnSOD transgenic mice does not provide intrinsic lung irradiation protection. Int J Cancer 96 (2001) 11-21
20. Carpenter M., Epperly M.W., Agarwal A., Nie S., Hricisak L., Niu Y., and Greenberger J. Inhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradiation damage. Gene Ther 2 (2005) 685-693
21. Tsubokawa T., Jadhav V., Solaroglu I., Shiokawa Y., Konishi Y., and Zhang J.H. Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 38 (2007) 1057-1062
22. Zhang H.W., Wang F.S., Shao W., Zheng X.L., Qi J.Z., Cao J.C., and Zhang T.M. Characterization and stability investigation of Cu, Zn-superoxide dismutase covalently modified by low molecular weight heparin. Biochemistry (Moscow) 71 suppl. 1 (2006) S96-S100
23. Snider G.L., Celli B.R., Goldstein R.H., O'Brien J.J., and Lucey E.C. Clinic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin lung volumes, volume pressure relations, carbon monoxide uptake, and arterial blood gas studies. Am Rev Respir Dis 117 (1978) 289-293
24. Szapiel S.V., Elson N.A., Fulmer J.D., Hunninghake G.W., and Crystal R.G. Bleomycin-induced interstitial pulmonary in the nude athymic mouse. Am Rev Respir Dis 120 (1979) 893-899
25. Mitchell A.D., and Taylor I.E. The spectrophotometric determination of hydroxyproline: An analytical investigation. Analyst 95 (1970) 1003-1011
26. Eitzman D.T., McCoy R.D., Zheng X., Fay W.P., Shen T., and Ginsburg D. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97 (1996) 232-237
27. Bergman L., and Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 35 (1963) 1961-1965
28. Woessner J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93 (1961) 440-447
29. Savani R.C., Zhou Z., Arguiri E., Wang S., Vu D., Howe C.C., and DeLisser H.M. Bleomycin-induced pulmonary injury in mice deficient in SPARC. Am J Physiol Lung Cell Mol Physiol 279 (2000) L743-L750
30. Entzian P., Schlaak M., Seitzer U., Bufe A., Acil Y., and Zabel P. Anti-inflammatory properties of colchicines: implications for idiopathic pulmonary fibrosis. Lung 175 (1997) 41-51
31. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 2nd ed. (1989), Clarendon Press, Oxford
32. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 3rd ed. (1998), Clarendon Press, Oxford
33. Venkataraman S., Jiang X., Weydert C.J., Zhang Y., Zhang H.J., Goswami P.C., and Ritchie J.M. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 24 (2005) 77-89
34. Oberley L.W., and Buettner G.R. The role of superoxide dismutase in cancer: a review. Cancer Res 39 (1979) 1141-1149
35. Weydert C., Roling B., Liu J., Hinkhouse M.M., Ritchie J.M., Oberley L.W., and Cullen J.J. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther 2 (2003) 361-369
36. Allen R.G., and Balin A.K. Developmental changes in the superoxide dismutase activity of human skin fibroblasts are maintained in vitro and are not caused by oxygen. J Clin Invest 82 (1988) 731-734
37. Balin A.K., Pratt L., and Allen R.G. Effects of ambient oxygen concentration on the growth and antioxidant defenses of human cell cultures established from fetal and postnatal skin. Free Radic Biol Med 32 (2002) 257-267
38. Oberley L.W. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother 59 (2005) 143-148
39. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30 (2001) 1191-1212
40. Fujita T., Nishikawa M., Tamaki C., Takakura Y., Hashida M., and Sezaki H. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J Pharmacol Exp Ther 263 (1992) 971-978
41. Fujita T., Furitsu H., Nishikawa M., Takakura Y., Sezaki H., and Hashida M. Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion. Biochem Biophys Res Commun 189 (1992) 191-196
42. Takakura Y., Mihara K., and Hashida M. Control of the disposition profiles of proteins in the kidney via chemical modification. J Controlled Release 28 (1994) 111-119
43. Tyagi S.C., Kumar S., and Katwa L. Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells. J Mol Cell Cardiol 29 (1997) 391-404
44. Asselot-Chapel C., Combacau L., Labat-Robert J., and Kern P. Expression of fibronectin and interstitial collagen genes in smooth muscle cells: modulation by low molecular weight heparin fragments and serum. Biochem Pharmacol 49 5 (1995) 653-659
45. El Nabout R., Martin M., Remy J., Robert L., and Lafuma C. Heparin fragments modulate the collagen phenotype of fibroblasts from radiation-induced subcutaneous fibrosis. Exp Mol Pathol 51 (1989) 111-122
46. Castellot J.J., Wong K., Herman B., Hoover R.L., Albertini D.F., Wright T.C., Caleb B.L., and Karnovsky M.J. Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol 124 1 (1985) 13-20
47. Adachi T., Hara H., Yamada H., Yamazakic N., Yamamoto M., Sugiyama T., Futenma A., and Katagiri Y. Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts. Atherosclerosis 159 (2001) 307-312
48. Hodl R., and Klein W. The role of low-molecular-weight heparins in cardiovascular medicine. J Clin Pharm Ther 28 (2003) 371-378
49. Qi J.Z., Wang F.S., Zhang H.W., Cao J.C., and Zhang T.M. Chemical modification of superoxide disnmtase by low molecular weight heparin and their physical and chemical properties. Chin Pharm J 41 (2006) 150-153
50. Anscher M.S., Kong F.M., Marks L.B., Bentel G.C., and Jirtle R.L. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 37 (1997) 253-258
51. Franko A.J., Sharplin J., Gahary A., and Barcellos-Hoff M.H. Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and 'non-fibrosing' mice during the latent period and early phase after irradiation. Radiat Res 147 (1997) 245-256
52. Morgan G.W., and Breit S.N. Radiation and the lung: a revaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 31 (1995) 361-369
53. Shepherd V.L. Cytokine receptors of the lung. Am J Respir Cell Mol Biol 5 (1991) 403-410
54. Snider G.L. Interstitial pulmonary fibrosis: which cell is the culprit?. Am Rev Res Dis 127 (1983) 535-539
55. Rubin P., Johnston C.J., Williams J.P., McDonald S., and Finkelstein J.N. A perpetual cascade of cytokines post-irradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33 (1995) 99-109
56. Moeller A., Ask K., Warburton D., Gauldie J., and Kolb M. The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. Int J Biochem Cell Biol 40 (2008) 362-382